---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-067306"
form_type: "8-K"
ticker: "LRMR"
cik: "0001374690"
company_name: "Larimar Therapeutics, Inc."
filed_at: "2024-05-31T23:59:59+00:00"
generated_at: "2026-06-01T07:07:01.856929+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Larimar Therapeutics shareholders elect Class I directors, approve all proposals at 2024 annual meeting

## Summary
- Jonathan Leff and Jeffrey Sherman re-elected as Class I directors with ~40.7M and ~51.1M votes for, respectively.
- Advisory vote on executive compensation approved with ~48.8M for, ~2.4M against.
- Ratification of PricewaterhouseCoopers LLP as auditor for FY2024 approved with ~59.6M for.
- Amendment to certificate of incorporation regarding officer exculpation approved with ~50.9M for.

## SEC filing metadata
- accession: 0000950170-24-067306
- form_type: 8-K
- ticker: LRMR
- cik: 0001374690
- company_name: Larimar Therapeutics, Inc.
- filed_at: 2024-05-31T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1374690/000095017024067306/0000950170-24-067306-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1374690/000095017024067306/lrmr-20240529.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-067306
- JSON: https://secwatch.observer/filing/0000950170-24-067306.json
- Plain text: https://secwatch.observer/filing/0000950170-24-067306.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.